跳至主要内容
临床试验/NCT06000709
NCT06000709尚未招募4 期

Randomized, Double-blinded, Comparison Between Ultrasound-Guided Genicular Nerve Phenol Neurolysis and Intra-articular Steroid Injections

University of Manitoba0 个研究点目标入组 40 人开始时间: 2023年10月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
入组人数
40
主要终点
Pain scores (Numeric Rating Scale) at 3 months

研究概览

简要总结

Genicular nerve neurolysis (GN) constitutes a relatively novel technique, whereby different chemical compounds (i.e. alcohol, phenol) are injected in close proximity to the genicular nerves of the knee joint, with the intention to exert a neurolytic effect by denaturing proteins resulting in Wallerian degeneration distal to the lesion. Based on the preliminary evidence and considering the potential benefits of the technique, we hypothesized that ultrasound-guided genicular chemical neurolysis with phenol is superior in terms of pain relief at 3 months, when compared to intra-articular steroid (IAS) injection.

详细描述

This study will allow us to determine if ultrasound-guided phenol genicular neurolys is superior to intra-articular steroid injection in terms of analgesia and functional outcomes, providing a more effective and long-lasting alternative for patients with chronic knee pain secondary to osteoarthritis

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Severe knee pain for more than 6 months, defined as Numeric rating scale (NRS) score of 6 and greater, unresponsive to conservative medical treatment
  • Radiological OA grade 2 to 4 (Kellgren-Lawrence scale)

排除标准

  • Previous total knee replacement on the index knee
  • Prior knee radiofrequency ablation on the index knee
  • Connective tissue diseases with knee involvement (e.g. rheumatoid arthritis)
  • Body mass index ≥ 40 kg/m2
  • Uncontrolled coagulopathy, defined as supratherapeutic dose of anticoagulation medication
  • Allergy to local anesthetics
  • Unstable opioid consumption, defined as an increase >10% in dosage during the last 3 months prior to recruitment.

研究组 & 干预措施

Ultrasound-guided Genicular Nerve Phenol Neurolysis

Experimental

One time injection of 1.5 mL of phenol 6% at 3 target locations: superomedial, superolateral and inferomedial genicular nerves

干预措施: 6% aqueous phenol (Drug)

Ultrasound-guided Genicular Nerve Phenol Neurolysis

Experimental

One time injection of 1.5 mL of phenol 6% at 3 target locations: superomedial, superolateral and inferomedial genicular nerves

干预措施: Intraarticular Knee Placebo (Drug)

Ultrasound-guided Intraarticular Steroid Injection

Active Comparator

Intraarticular knee injection of 40 mg of methylprednisolone acetate in a volume of 5 mL of saline

干预措施: MethylPREDNISolone 40 MG (Drug)

Ultrasound-guided Intraarticular Steroid Injection

Active Comparator

Intraarticular knee injection of 40 mg of methylprednisolone acetate in a volume of 5 mL of saline

干预措施: Genicular Nerve Placebo (Drug)

结局指标

主要结局

Pain scores (Numeric Rating Scale) at 3 months

时间窗: 3 months

Knee pain intensity using Numeric Rating Scale ranging from 0 to 10 (0 = no pain and 10 = worst imaginable pain)

次要结局

  • Pain scores (Numeric Rating Scale) at baseline, 1 and 6 months(baseline, 1 month, 6 months)
  • Proportion of patients experiencing a 50% or greater decrease in baseline knee pain scores (NRS)(1 months, 3 months, 6 months)
  • WOMAC index(baseline, 1 month, 3 months, 6 months)
  • Brief Pain Inventory Score (BPI)(baseline, 1 month, 3 months, 6 months)
  • Incidence of adverse events(from injection up to 1 month after intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Javier Webar

Assistant Professor

University of Manitoba

相似试验